Timothy Mullett, MD, leaned toward his computer screen as he spoke, drowning out the sounds of the busy coffee shop behind him to get his message across.

During a Case-Based Roundtable® event, Ticiana Leal, MD, discusses phase 3 trials of combinations in the non–small cell lung ...

Cancer is the second leading cause of death in the U.S., but research shows that at least 42% of new cancer cases are ...

Panelists discuss how to effectively collaborate with payers to ensure access to necessary medications for patients with small cell lung cancer (SCLC), while also exploring best practices for patient ...

Three tobacco giants would pay close to $25 billion to provinces and territories and more than $4 billion to tens of thousands of Quebec smokers and their loved ones as part of a newly proposed deal ...

Goshen Center for Cancer Care is recognizing the completion of 50 procedures utilizing cutting-edge robotic technology to ...

A significant weapon in the fight against lung cancer may be going to waste, as a survey revealed most Americans aren’t aware ...

In the randomized, double-blind, phase 3 study, experts explored treatment with neoadjuvant pembrolizumab (Keytruda) plus chemotherapy, followed by adjuvant pembrolizumab, in patients aged 18 years ...

Receiving a cancer diagnosis can be intimidating, but it’s important to remember that it doesn’t mean you have to stop living ...

Novocure received a long-sought FDA approval for the use of its Tumor Treating Fields technology against metastatic non-small ...

Cervical cancer remains the most widespread cause of cancer death in women in the country, accounting for 12 percent of all cancer deaths recorded in Zimbabwe. Prostate cancer is the second most ...

Prenetics Global Limited, a leading health sciences company, today announced that Tencent has made a strategic US$30 million investment in Insighta, a Hong Kong -based early cancer detection company.